Multiple scan modes in the hybrid tandem mass spectrometric screening and characterization of the glutathione conjugate of 2-furamide  by Ballard, Kevin D. et al.
Multiple Scan Modes in the Hybrid Tandem 
Mass Spectrometric Screening and 
Characterization of the Glutathione 
Conjugate of 2-Furamide 
Kevin D. Ballard, Mark J_ Raftery, Hartmut Jaeschke, and Simon J. 
Gaskell 
Center for Experimental Therapeutics, Baylor College of Medicine, Houston, Texas, USA 
The glutathione conjugate of 2-furamide has been screened for and structurally character- 
ized by tandem mass spectrometry (MS/MS) by using a hybrid instrument of BEqQ design. 
Mass spectrometry experiments employed fast atom bombardment (FABI ionization of a 
crude bile extract from a rat dosed with a 1:l mixture of unlabeled and [ %,]2-furamide. 
Initial screening for glutathione conjugates employed constant neutral loss scanning to 
detect the loss of 129 u, corresponding to the loss of the y-glutamyl moiety of the 
conjugates. By direct comparison with control bile, [M + H]+ ions of m /z 417 and 418 were 
readily identihed as candidate ions corresponding to the glutathione conjugates of unla- 
beled and 13C-labeled Zfuramide. Complementary screening information was generated by 
using a methylated bile extract, with constant neutral loss scanning to detect the loss of the 
methylated r-glutamyl moiety (143 u). An alternative screening procedure employing 
parent ion scanning to detect the sodium adducts of methylated glutathione conjugates was 
also developed. Structural information was generated by first-generation product ion 
scanning of the protonated and sodium cationized forms of the candidate species, both 
native and derivatized. This provided a body of internally consistent evidence that the 
conjugate retains the pseudoaromatic furan ring system without ring hydroxylation. The 
utaity of sequential mass spectrometry (MS/MS/MS) capability of the hybrid instrument in 
the analysis of complex biological mixtures was also demonstrated. Using the bile extract, 
&St-generation product ions that formed in either the first or second held-free region of the 
double-focusing portion of the instrument were subsequently collisionally activated in the 
rf-only quadrupole followed by mass analysis of the second-generation product ions. 
Structural information so provided for the glutathione conjugate of 2-furamide further 
substantiated its retention of the pseudoaromatic furan ring system and facilitated plausible 
assignment of structures to ionic species generated through multiple decomposition events. 
(J Am Sot Mass Spectrom 2991, 2, 55-68) 
N umerous drugs and other xenobiotics have been demonstrated to undergo hepatic metabolic activation to highly reactive elec- 
trophilic intermediates that have the potential to react 
with hepatic macromolecules with toxic conse- 
quences. ln many instances, conjugation of these in- 
termediates with hepatic glutathione (y-glutamylcys- 
teinylglycine), yielding the general structure I, repre- 
sents an important detoxification pathway, such that 
when hepatic stores of glutathione are depleted the 
toxic properties of the xenobiotic become manifest; 
acetaminophen has become a classic example in ex- 
hibiting this mode of toxicity [l-4]. Because a knowl- 
edge of the structure of the glutathione conjugate(s) 
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of reactive intermediates yields insight into the toxic 
mechanisms involved, the identification and struc- 
tural characterization of glutathione conjugates have 
become increasingly important, particularly with the 
continuing development of new drugs with the po- 
tential for drug-induced injury. 
Xenobiotics that behave in the above manner are 
described as exhibiting a glutathione threshold of toxi- 
city. Various substituted furans show differing behav- 
ior in this regard [5]; it is not clear whether this is 
associated with differences in metabolism, differing 
affinities for glutathione transferases, or other factors. 
As part of a broad study of these issues, the experi- 
ments descrl%ed here involved the use of 2-furamide, 
which exhibits a glutathione threshold of toxicity, as a 
model compound. The major objective of the present 
study was to identify and structurally characterize the 
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glutathione conjugate(s) of this compound formed in 
vivo. 
Numerous mass spectrometric approaches to the 
characterization of glutathione conjugates have been 
assessed previously, including electron ionization (EI) 
[6], chemical ionization (CI) [7], desorption chemical 
ionization (DCI) [S, 91, held desorption (FD) [IO-141, 
fast atom bombardment (FAB) and liquid secondary 
ion mass spectrometry (LSIMS) 115-341, and liquid 
chromatography-thermospray mass spectrometry 
[35-411. In general, more success has been achieved 
using the softer ionization techniques (FD, FAB, 
LSIMS, and thermospray) that generate abundant [M 
+ H] + ions, which may then be subjected to 
collision-activated decomposition (CAD) conditions. 
The resulting structurally informative fragment ions 
may be analyzed by various tandem mass spectromet- 
ric (MS/MS) approaches. 
A general analytical strategy for the FAB/MS/MS 
identification and characterization of xenobiotic-de- 
rived glutathione conjugates has previously been re- 
ported from this laboratory [30]. This strategy in- 
volved high-performance liquid chromatographic 
(HPLC) isotation of appropriate fractions of extracts of 
biological material, followed by constant neutral loss 
scanning as a compound class selective screening pro- 
cedure to facilitate the detection of putative glu- 
tathione conjugates. For the constant neutral loss 
scans, a hybrid tandem mass spectrometer was set to 
monitor the loss of 129 u, corresponding to the loss of 
the y-glutamyl moiety from the glutathione backbone 
of the conjugates. Precursor ions so identified by the 
screening procedure were then analyzed by product 
ion scanning to generate structural information. The 
well-characterized glutathione conjugate of ac- 
etaminophen was employed as a model compound 
for those studies. Other investigators subsequently 
employed a similar MS/MS approach to screen for 
and characterize glutathione conjugates of several 
xenobiotics as N-benzyloxycarbonyl-bismethyl ester 
derivatives, which possess desirable chromatographic 
properties for HPLC isolation [29, 31, 321. These 
derivatives also exhibit a characteristic loss of glycine 
methyl ester (89 u) as a neutral species, such that 
constant neutral loss scanning was again useful as a 
screening strategy [42]. 
During the present investigation of the metabolism 
of 2-furamide, the capabilities of hybrid MS/MS were 
used to greater advantage than previously, to permit 
the analysis of crude extracts of biological material 
without the need for elaborate purification schemes. 
Three alternative screening strategies involving sim- 
ple derivatization were developed to provide informa- 
tion complementary to that of the original approach 
[30]. The variety of scan modes accessible on the 
hybrid instrument has been more extensiveIy ex- 
ploited, including two alternative approaches to se- 
quential mass spectrometry (MS/MS/MS) that pro- 
vide highly specific structural information from crude 
biological material. 
Experimental 
Materials 
Unlabeled Zfuramide was obtained from Eastman Ko- 
dak Co. (Rochester, NY). AU solvents were of HPLC 
grade and were used without further purification. 
Acetyl chloride (J.T. Baker Chemical Co., Phillips- 
burg, NJ) and heptafluorobutyric acid (Peninsular 
Chemresearch, Inc., Plainview, NY) were redistilled 
under argon prior to use. [‘H,]Methanol (isotopic 
purity 99%) was purchased from MSD Isotopes 
(Montreal, Canada). All glassware used in these ex- 
periments was surface-deactivated by treatment with 
dichlorodimethylsilane/toluene (4/% v/v) for 20 min 
followed by an absolute methanol rinse. 
Synthesis of [‘3C,]2-Furanzide 
2-Furyllithium was produced by the method of Ra- 
manathan and Levine [43]. Dry [?]carbon dioxide 
[produced by dropwise addition of dilute hydrochlo- 
ric acid onto Ba13C0, (isotopic purity > 98%; Aldrich, 
Milwaukee, WI) and dried by passage through anhy- 
drous CaS04] was bubbled through the 2-furyllithium 
to produce [‘3C]2-furoic acid, with the label in the 
carbonyl position. This product was then converted to 
the acid chloride [44] and amidated by using reported 
procedures [45]. 
Animal Experiments 
Male Fischer rats (230-320 g) were anesthetized with 
sodium pentobarbital, and a laparotomy was per- 
formed followed by bile duct cannulation with PE-10 
tubing. Control bile was collected from each animal 
for 30 min. 2-Furamide, either pure unlabeled or a 1:l 
mixture of unlabeled and 13C-labeled, was adminis- 
tered intraperitoneally in 1.5 mL of saline at a total 
dose of 200 mg/kg. Bile was collected into preweighed 
glass vials over 15-30-min intervals for a 2-h time 
period. The collected samples were then weighed and 
stored at -20 “C. 
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lowPairing Extraction of Bile 
Bile samples were rendered 1% by volume in hep- 
tafluorobutyric acid (HFBA) [46, 471. Reverse-phase 
(C,) Sep-Paks (Waters Associates, Milford, MA) were 
charged with acetonitrile and washed with 10 mL of 
0.1% aqueous HFBA. The samples were loaded, 
washed with 10 mL of 0.1% aqueous HFBA, and then 
eluted with 4 mL of acetonitrile/water (4/l) contain- 
ing 0.1% HFBA. The extracts were evaporated under 
nitrogen to remove excess acetonitrile, lyophilized, 
and redissolved in 200 gL of acetonitrile/water (4/l) 
containing 0.1% HFBA. Aliquots (l-2 FL) of the final 
solutions were used for MS/MS analysis. 
Derivattition Reactions 
Aliquots (25% of the total) of the crude bile extracts 
were evaporated to dryness under nitrogen and meth- 
ylated using freshly generated methanolic HCl. Acetyl 
chloride (440 aL) was slowly added to 1.56 mL of 
methanol at 0 “C under nitrogen, and this mixture 
was allowed to stand at 0 “C for 30 min. Approxi- 
mately 0.5 mL of this reagent was added to each dry 
bile extract, and the mixtures were allowed to stand at 
room temperature for 1 h. The samples were then 
taken to dryness under nitrogen, followed by re- 
peated additions of several drops of methanol and 
reevaporation to ensure removal of excess HCl. The 
dry samples were redissolved in 50 PL of methanol. 
Methylation/deuteromethylation of crude bile ex- 
tracts was performed identically except that the meth- 
ylating reagent was prepared by using 290 PL of 
acetyl chloride and 1 mL of a 1:l mixture of unlabeled 
methanol and [‘H,]methanol. 
Mass Spectromet y 
Tandem mass spectrometric analyses were performed 
with a VG ZAB-SEQ (VG Analytical Ltd., Manch- 
ester, UK), a hybrid mass spectrometer of BEqQ de- 
sign (B = magnetic sector, E = electric sector, q = rf- 
only quadrupole, and Q = quadrupole mass filter). 
Fast atom bombardment ionization was employed 
with xenon for the primary atom beam, with the FAB 
gun operated at an energy of 8 keV. The FAB matrix 
was a 1:l mixture of 2,2’-dithiodiethanol and thioglyc- 
erol, saturated with oxalic acid. The double-focusing 
portion of the hybrid instrument was typically oper- 
ated at a resolution of 1200-1500, with the quadrupole 
mass titer typically operated at l-l.5 u resolution. All 
scan data were acquired in the multichannel analyzer 
(MCA) mode of the VG 11/2NJ data system to facili- 
tate evaluation of the quality of the raw data, with six 
to eight scans typically accumulated. In some in- 
stances, these data were subsequently converted to a 
histogram format via the data-system. It should be 
noted that the apparent resolution of full-scan plots of 
MCA data may appear artifactually degraded because 
of the compression algorithms incorporated in the 
plotting routines of the data system. 
Conventional FAB spectra were recorded by using 
the double-focusing portion of the hybrid instrument. 
First-generation product ion spectra were obtained by 
manual selection of the precursor ion with the 
double-focusing portion of the instrument, with sub- 
sequent scanning of the quadrupole mass filter to 
detect the h&-generation product ions formed in the 
rf-only quadrupole. Collision-activated decomposition 
conditions were employed for these experiments with 
argon as the target gas at a pressure of 1 x 10e6 mbar 
in the analyzer housing, corresponding to an esti- 
mated pressure in the collision region of 1.8 x 1O-4 
mbar; the collision energy ranged from 6 to 70 eV in 
the laboratory frame of reference. Constant neutral 
loss Scans were obtained by simultaneously scanning 
the magnet and the quadrupole mass filter under the 
conhol of the data system with a constant mass offset 
of either 129, 143, or 146 u and a collision energy of 8 
eV. For precursor ion scans the quadrupole mass filter 
was set to transmit the product ion of interest (m/z 
324 in these experiments), and the magnet was 
scanned over a broad range to sequentially introduce 
the source-formed precursor ions into the &only 
quadrupole; CAD conditions for these experiments 
were again 1.8 x 10F4 mbar argon in the rfionly 
quadrupole, with a collision energy of 22 eV. 
Second-generation product ion spectra (MS/MS/ 
MS) were obtained in two ways. The hrst approach 
involved manual selection of first-generation product 
ions formed in the second held-free region of the 
mass spectrometer (FFR2) under metastable condi- 
tions. (For the MS/MS/MS analyses reported here, 
no significant improvement in signal intensity was 
achieved by incorporation of collision gas in FFR2.) 
The magnetic field strength was adjusted to select the 
precursor ion, followed by adjustment of the electric 
sector to select the fnst-generation product ion (effec- 
tive mass resolution 300) using a previously described 
instrument modification that permits independent 
control of the electric sector held strength [48]. First- 
generation product ions so selected were subjected to 
collisional activation in the rf-ordy quadrupole (1.5 x 
10s4 mbar argon, 70 eV collision energy), with subse- 
quent mass analysis of the second-generation product 
ions with the quadrupole mass filter; lo-15 scans 
were accumulated by the data system in MCA mode. 
For the second approach to MS/MS/MS, appropri- 
ate settings of the magnetic and electric sector field 
strengths were established to select hrst-generation 
product ions formed in the first field-free region (FFRl) 
of the mass spectrometer. These settings were first 
adjusted to transmit product ions formed in FFR2 in 
the manner described above to permit optimization of 
the electric sector setting. The magnetic field strength 
was then readjusted to a nominal value of mz/mp, 
where mf is the mass of the hrst-generation product 
ion and mP is the mass of the precursor ion. The 
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Figure 1. (a) Conventional FAB mass 
spectrum of a crude bile extract from a 
rat dosed with a I:1 mixture of unlabeled 
and [‘3C,]2-furamide. (b) constant neu- 
tral loss spectrum (monitoring the loss of 
129 u) of the same bile sample as in (a). 
(c) Constant neutral loss spectrum (129 
u) of control bile extract from the same 
animal as in (a) and (b) prior to adminis- 
tration of 2-furamide. Signals in the con- 
stant neutral loss spectra are labeled as 
the m/z ratios of the precursor ions. 
instrumental settings were thus appropriate for trans- 
mitting into the rf-only quadrupole collision region 
frrst-generation product ions of mass mf formed from 
precursor ions of mass mt, in FFRl. First-generation 
product ions were then collisionally activated as de- 
scribed above, and the second-generation product ions 
so formed were again mass-analyzed as described 
above. 
Results 
The analytical strategy used in these studies involved 
extraction of the biological material, followed by com- 
pound class selective screening by hybrid MS/MS, 
with subsequent structural analysis of compounds 
identified as pertinent by the saeening procedures. 
Thus, initial studies focused on detecting the presence 
of Z-furamide-derived glutathione conjugates in crude 
bile extracts from rats dosed with the model com- 
pound. To facititate these studies, the isotope cluster, 
or “twin ion,” technique [49] was employed using a 
1:l mixture of unlabeled and 13C-labeled 2-furamide, 
with the stable-isotope-Iabeled material incorporating 
a single 13C atom located in the carbonyl group. 
Whereas stable-isotope-Iabeled compounds differing 
from their unlabeled analogues by 1 II generally do 
not serve well as internal standards for quantitative 
purposes [%I], for qualitative mass spectrometric ap- 
plications a 1:l doublet separated by 1 u is the sim- 
plest pattern for pattern recognition. This approach is 
particularly valuable for the recognition of metabolites 
in complex biological extracts. Even with the twin ion 
technique employed, however, [M + H]+ ions at- 
trrbutable to xenobiotic-derived material are not al- 
ways obvious io the conventional FAB spectra of 
complex mixtures. This is exemplified in Figure la, 
which presents the conventional FAB spectrum of a 
crude bile extract from a rat dosed with the I:1 mix- 
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Figure 3. Expanded portions of con- 
stant neutral loss spectra (monitoring the 
loss of 146 u) of (a) xenobiotic-treated 
and (b) control bile extracts after meth- 
) 
1 
ylation with 3 M HCI in a 1:l mixture of 
unlabeled methanol and [*H4] methanol. 
with methanolic HCl. Constant neutral loss spectra of 
the methylated xenobiotic-treated and control extracts 
are presented in Figures 2a and 2b, respectively; in 
this case the instrument was set to monitor the loss of 
143 u, corresponding to the loss of the y-glutamyl 
moiety as the methyl ester. These spectra were quali- 
tatively similar to the corresponding spectra of the 
unmethylated material (Figures lb and lc), except 
that the masses of the major peaks were shifted by 
multiples of 14 u, indicating the number of methylat- 
able functions, presumably carboxylic acid groups, 
present in the native material. Reduced glutathione 
was shifted from m/z 308 to m/z 336, consistent 
with the presence of two carboxylic acid groups; simi- 
larly, oxidized glutathione was shifted from m/z 613 
to m/z 669, consistent with the presence of four 
functions amenable to methylation. The 1:l doublet at 
WI /.z 4171418 was shifted to m 1.z 445/446, which is 
consistent with two carboxylic acid groups and thus 
TIME (msec) 
*\ 
1 146 u 
0’ 
further indicates the candidacy of these species as 
glutathione conjugates. 
Simple methylation followed by constant neutral 
loss scanning employing a mass offset of 143 u can 
thus form the basis of an alternative screening strat- 
egy for the detection of glutathione conjugates. This 
procedure was extended to include methylation with 
3 M HU in a 1:l mixture of unlabeled methanol and 
[‘H,]methanol. Dicarboxylic acids so methylated gen- 
erate an [M + H]+ ion isotopic pattern consisting of a 
triplet of ions separated by 3 u, with relative intensity 
ratios of 1:2:1, corresponding to the [lHg, 2H,,], [lH3, 
*H,l, and ilHo, ‘H,] forms of the derivative. For a 
glutathione conjugate, a scan for the loss of a neutral 
specie; of 143 u would detect the [lH,, 2H,] and 
[ H,, H3] forms of the derivative as a 1:l doublet 
separated by 3 u. Similarly, a scan for the loss of a 
neutral species of 146 u would detect the [IH,, 2H,] 
and [IHa, ‘H6] forms, again as a 1:l doublet sepa- 
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rated by 3 u. With the twin ion technique employed 
in conjunction with this procedure, xenobiotic-de- 
rived conjugates should appear as a quartet (two 
overlapping doublets) in the constant neutral loss 
spectra with a mass offset of either 143 or 146 u. An 
expanded portion of a constant neutral loss spectrum 
(146 u) from the xenobiotic-treated bile extract that 
was methylated in this manner is presented in Figure 
3a. The xenobiotic-related twin ions were detected as 
a quartet at m/z 448, 449, 451, and 452 under these 
conditions, corresponding to the [13Co, ‘Ha], [%,, 
2H3], [13C,,, ‘H,], and [r3C,, 2H,] forms of the 
derivatized conjugates. The apparent distortion in the 
relative intensity of the m/z 443 ion was due to a 
contributing signal from the m/z 445/448 doublet, 
which was also present in the control bile (Figure 3b). 
Structural information was generated through 
scanning the first-generation product ions formed 
from the protonated and sodium cationized forms of 
Figure 4. Low-energy CAD fmt-gen- 
eration product ion spectra of the m/z 
417 (a and c) and m/z 418 (b and d) 
species from xenobiotic-treated bile ex- 
tract. The spectra in (a) and (b) were 
acquired under 6-eV CAD conditions; 
those in (c) and (d) were acquired under 
7O-eV CAD conditions. 
the candidate conjugate species with the native and 
derivatized crude bile extracts. Low-energy CAD (6 
eV) first-generation product ion spectra of the m/z 
417 and 418 (protonated) species are presented in 
Figures 4a and 4b. The single-letter nomenclature 
employed here for the proposed fragmentations (de- 
picted in Figure 5) is the same as that employed 
previously [30] and subsequently adopted by others 
[32,34]. The molecular masses of the candidate species 
identified by the screening procedures suggested a 
conjugate structure that retained the pseudoaromatic 
character of the furan ring system without ring hy- 
droxylation, and the first-generation product ion spec- 
tra were consistent with this hypothesis. Under low- 
energy CAD conditions (6-8 eV) the putative e ions 
(m/z 288/Z&39), corresponding to the highly favored 
loss of the y-glutamyl moiety, dominated the spectra 
and differed by 1 u between the two spectra, as did 
other ions believed to contain the isotopic variants of 
62 BALLARD ET AL J Am Sot Mass Spectrom 1!391,2,55-68 
Figure 5. Proposed fragmentations of 
m/z 417 and structures of the ionic 
species observed in Figure 4. The aster- 
isks indicate the location of the 13C label. 
The indicated m/z values correspond to 
the unlabeled material. Fragmentation of 
the precursor structure is shown relative 
to the neutral molecule, without implica- 
tion as to the site of initial protonation. 
the xenobiotic-derived side chain (a, c, and d ions). 
Conversely, the m /z 274 (k) ion, apparently derived 
through loss of the side-chain substituent, was pre- 
sent in both spectra. Other ions indicative of the 
nature of the side chain were generated at a some- 
what higher collision energy (70 eV), as depicted in 
Figures 4c and 4d, where the d, g, and h ions were 
detected at higher relative abundance. Proposed 
structures for these ions are shown in Figure 5. The 
overall fragmentation pattern observed in these spec- 
tra is consistent with that observed previously for a 
variety of glutathione conjugates [30]. A similar frag- 
mentation pattern was observed for the sodium 
cationized forms of the candidate (underivatized) 
species, with appropriate 22-u shifts observed for the 
fragment ions. 
Complementary structural information is provided 
by the frrst-generation product ion spectra of the 
methylated material (Figures 6a and 6b). In these 
spectra, ions apparently incorporating the side-chain 
elements differ by 1 u between the two spectra, and 
appropriate 14-u shifts were observed between the 
ions of these spectra and those of the unmethylated 
material (Figure 4). The e ions are again dominant in 
these low-energy (6 eV) CAD spectra, thus forming 
the basis of the alternative screening strategy dis- 
cussed above that employed constant neutral loss 
scanning with a mass offset of 143 u. Interestingly, 
the first-generation product ion spectra of the sodium 
adducts of the methylated candidate species are both 
dominated by a single product ion of m/z 324, as 
depicted ln the expanded spectral regions shown in 
:,c ‘NH, 
0 
0 
CH 
m/z 168 
h 
m/z 213 
m 
m/z 144 
d 
m/z 730 
n 
Figure 7a and 7b. This observation was attributed to a 
sodium-induced alteration in the relative predomi- 
nance of competing fragmentation pathways, such 
that loss of the side chain is the predominant pathway 
for the sodium cationized, methylated species (giving 
rise to the sodium cationized, bismethylated analogue 
of the m/z 274 (k) ion observed with the native 
material in Figures 4a and 4b), as opposed to the 
predominance of the loss of the y-glutamyl moiety (e 
ion) with the protonated species. Whereas these ions 
were isobaric for the unlabeled material, the relative 
contributions from the two alternative fra mentation 
pathways were well visualized with the % C-labeled 
material (Figure 7b). The observation of an intense ion 
common to both spectra in Figure 7 suggested the 
possibility of employing precursor ion scanning as 
another alternative screening procedure. A precursor 
ion scan of the methylated xenobiotic-treated bile ex- 
tract, with the tandem hybrid instrument set to scan 
for precursors of m/z 324, is presented in Figure 8. 
Reduced and oxidized glutathione were again de- 
tected, and the candidate 2-furamide conjugates ap- 
peared as a doublet at m/z 467/468. The distortion of 
the relative intensities of these ions from a 1:l doublet 
was attributed to the contribution from the isobaric e 
ion from the m /z 467 material. It should be noted that 
no supplemental sodium was added to the sample or 
matrix in obtaining the spectra of Figures 7 and 8; the 
trace amounts of the ubiquitous sodium contaminant 
present in these “desalted” samples was sufficient to 
permit the acquisition of these scans. 
Further structural information for the candidate 
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Figure 6. Low-energy CAD (6eV) 
hrst-generation product ion spectra of (a) 
m iz 445 and (bl m/z 446 suecies from 
the methylated.xenobiotic-treated bile ex- 
tract. 
conjugate species was generated through second-gen- 
eration product ion scanning (MS/MS/MS) using ei- 
ther of two approaches possible with the BEqQ tan- 
dem hybrid instrument. In the frrst approach, source- 
formed precursor ions selected with the magnet (m/z 
417 or 418) were allowed to decompose through 
metastable decay in FFR2 to yield the &t-generation 
product ions. The ions corresponding to the loss of 
the y-glutamyl moiety (m/z 288 or 289) were then 
selected with the electric sector and subjected to colli- 
sional activation (70 eV) in the rf-only quadrupole. 
The second-generation product ions thus formed were 
analyzed by the quadrupole mass ftlter. The resulting 
second-generation product ion spectra from the xeno- 
biotic-treated bile extracts are presented in Figure 9. 
These spectra clearly demonstrate that the putative d, 
g, and h ions were derived from the putative e ions, 
with appropriate l-u shifts between the isotopic vari- 
ants. The m/r 130 ion (which is also observed in 
Figure 4) is common to the two spectra. In the ab- 
sence of the MS/MS/MS data, the origin of the m/z 
130 ion is ambiguous; however, the observation that 
this ion was formed as a second-generation product 
from the e ion, together with its lack of incorporation 
of the xenobiotic-derived side chain, permits the plau- 
sible attribution of this ion to the structure shown in 
Figure 5. 
The above approach to MS/MS /MS has the advan- 
tages of good resolution of the precursor and second- 
generation product ions, but poor (ca. 300) effective 
resolution of the first-generation products. In an alter- 
native approach, first-generation product ions formed 
in FFRl rather than FFR2 are introduced into the 
rf-only quadrupole under CAD conditions, with sub- 
sequent mass analysis of the resulting second-genera- 
tion products. This approach gives good resolution of 
the frrst- and second-generation product ions but poor 
effective resolution of the source-formed precursors 
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Figure 7. Expanded regions of the 
fust-generation product ion spectra of (a) 
m/z 467 and (b) m/z 468 species from 
the methylated bile extracts, correspond- 
ing to the sodium adducts of the meth- 
ylated glutathione conjugates of unla- 
beled and 13C1-labeled 2-furamide. 
k 
324 
[52]. Analysis of the xenobiotic-treated bile extract by 
this approach yielded spectra virtually identical to 
those of Figure 9, with the exception of the presence 
of a contaminating ion of m/r 137, which was 
demonstrated to be derived from the FAB matrix. 
Thus, even with the high structural specificity of 
MS/MS/MS techniques, the possibility of contribut- 
ing signals from the background must be considered. 
A summary of the ionic species observed from the 
candidate glutathione conjugates is presented in Fig- 
ure 10. These data form a body of internally consis- 
tent evidence supporting the identification of the glu- 
tathione conjugate of 2-furamide, with the 
xenobiotic-derived portion of the conjugate retaining 
the pseudoaromatic furan ring system without ring 
hydroxylation. These data do not permit the identi- 
cation of the location of substitution of the furan ring; 
high-energy CAD (8 keV), using the mass-resolved 
ion kinetic energy scanning (MIKES) approach, 
yielded fragmentation patterns similar to those ob- 
l afJ 
*‘l\’ 
OQ 
served with low-energy CAD and was therefore also 
uninformative in this regard. This issue is the subject 
of continuing study. 
The various scan modes employed in these studies, 
with their relative attributes and utilities, are tabu- 
lated in Table 1. Numerous other scan modes not 
pertinent to the present study are also accessible on 
this hybrid instrument. The unique versatility of this 
instrumental design makes it directly applicable to a 
wide variety of problems. 
Conclusions 
Application of a range of MS/MS techniques in the 
present study has resulted in the characterization of 
the glutathione conjugate resulting from the 
metabolism of Z-furamide as retaining the pseudoaro- 
matic furan ring without ring hydroxylation. Further 
investigations are required to establish the site(s) of 
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P 
Figure 8. Precursor ion scan of fhe 
methylated xenobiotic-treated bile ex- 
tract, monitoring precursors of m/z 324. 
d 
145 
e 
289 
. 418 
i 289 
odlLo 0 
Figure 9. Second-generation product 
ion specha (MS/MS/MS) from the xeno- 
biotic-treated bile extract. (a) Second- 
generation CAD products of M /Z 288 
derived from m&stable decay of m/z 
417; (b) second-generation CAD prod- 
ucts of m/z 289 derived from metastable 
decay of m/z 418. 
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Figure 10. Summary of the ionic species 
observed from the protonated and 
sodium cationized forms of the candidate 
glutathione conjugates from the native 
(unmodihed) and derivatized xeno- 
biotic-treated crude bile extracts. 
substitution of the furan ring. Previous metabolic 
studies of 24uramide suggested activation by mixed- 
function oxidases [53]. Although the mechanism of 
formation of the glutathione conjugate remains specu- 
lative, a plausible route involves initial epoxidation 
folIowed by nucleophilic substitution by glutathione 
and subsequent dehydration to restore the pseu- 
doaromatic structure. 
The twin ion technique has repeatedly been shown 
to facilitate drug metabolism studies. The use of com- 
pound class selective screening procedures, such as 
constant neutral loss or precursor ion scanning, in 
conjunction with this technique can further facilitate 
the rapid identihcation of candidate xenobiotic 
metabolites that may not be readily discernible in the 
conventional FAB spectra of complex biological mix- 
tures. The hybrid tandem mass spectrometer is partic- 
ularly well suited for complex mixture analysis. The 
Table 1. Scan modes used in the screening and characterization of glutathione conjugates 
Scan mode 
Acquisition 
Decompo- Effective 
sition Collision mass 
Static Scanned region energy resolution Application 
lst-generation Band E Q q 
product ion 
scan 
a-70 ev 
constant E BandQ q 
neutral loss 
scan 
8 eV 
precursor ion Qand E B q 
scan 
22 eV 
Znd-generation Band E Q FFR2 (1 
product ion ql21 
scan [mode 1 I 
1 Metastable (1 
70 eV(2) 
> 1000 (precursor); 
unit (1 st gen. products) 
Compound 
class screening 
1 > 1000 (precursorl; Highly 
ca. 300 (1st gen. productsl; specific 
unit (2nd-gen. products) structural 
information 
> 1000 (precursor); 
unit (I st gen. products) 
Structural 
information 
> 1000 (precursor); 
unit (1st gen. products) 
Compound 
class screening 
2nd.generation Band E Q FFAl (1) Metastable’ (1) Ca. 300 (precursor); Highly 
product ion q (21 70 eV(2) ca. 800 (1st.gen. products); specific 
scan (mode 2) unit (2nd.gen. products) structural 
information 
‘Whereas these decompositions ara nominally designated as metasrable, the potential exists for a significant contribution 
from CAD because of the presence of the FAB gas escaping from the ion source rkgion. 
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multiple scan modes that are readily accessible on 
hybrid sector/quadrupole instruments, together with 
facile control of collision energy regimes and the avail- 
ability of multiple approaches to MS/MS/MS, facili- 
tate the generation of readily interpretable screening 
and structural data even in the presence of compara- 
tively high chemical background. Furthermore, the 
individual experiments described here were relatively 
brief; in the application of these techniques to other 
unknown glutathione conjugates, the entire comple- 
ment of mass spectrometric analyses described here 
could be performed during two working days. Simple 
derivatization strategies can supplement the various 
MS/MS approaches to facilitate thorough characteri- 
zation of individual species within biological mixtures 
without the need for overly complicated purification 
schemes. 
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